Sugi Predict

Sugi Predict / Compounds / SCHEMBL1711313

SCHEMBL1711313

SCHEMBL1711313

CC(C)C(N)C(=O)NC(CCCCN)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 1/20 0.54
▸ CPB2 Q96IY4 8/20 0.49
▸ SLC6A5 Q9Y345 1/20 0.46
▸ GSR P00390 1/20 0.46
▸ DPP4 P27487 2/20 0.44
▸ DPP8 Q6V1X1 2/20 0.44
▸ DPP9 Q86TI2 2/20 0.44
▸ DPP7 Q9UHL4 2/20 0.44
▸ ERAP2 Q6P179 1/20 0.44
▸ ERAP1 Q9NZ08 1/20 0.44
▸ LNPEP Q9UIQ6 1/20 0.44
▸ NOD1 Q9Y239 1/20 0.43
▸ SLC15A2 Q16348 1/20 0.43
▸ FAP Q12884 1/20 0.42
▸ GNPAT O15228 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29358709 1.00 FOLH1 (0.54) FOLH1CPB2SLC6A5GSRDPP4
SCHEMBL29358689 1.00 FOLH1 (0.54) FOLH1CPB2SLC6A5GSRDPP4
SCHEMBL1711315 1.00 FOLH1 (0.54) FOLH1CPB2SLC6A5GSRDPP4
SCHEMBL29357446 1.00 FOLH1 (0.54) FOLH1CPB2SLC6A5GSRDPP4
SCHEMBL29782763 0.97 FOLH1 (0.51) FOLH1CPB2SLC6A5GSRDPP4
SCHEMBL29392005 0.95 FOLH1 (0.47) FOLH1CPB2SLC6A5GSRDPP4
SCHEMBL16862514 0.94 FOLH1 (0.49) FOLH1CPB2SLC6A5GSRDPP4
SCHEMBL16862515 0.94 FOLH1 (0.49) FOLH1CPB2SLC6A5GSRDPP4
SCHEMBL30578949 0.93 FOLH1 (0.48) FOLH1CPB2SLC6A5GSRDPP4
SCHEMBL30093154 0.93 FOLH1 (0.48) FOLH1CPB2SLC6A5GSRDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122060019-A Alpha-L-glutamate ligase and valine-lysine dipeptide preparation method 无锡职业技术大学 2026-05-19 — — CN claimed
US-20260027241-A1 Near-Infrared Dyes And Conjugates For Targeting Tumors LAHJAVIDA, INC. (US) 2026-01-29 — — US claimed
WO-2025129098-A1 TYROSINASE-BASED CONJUGATE COMPOSITIONS AND METHODS OF USE CATENA BIOSCIENCES, INC. (US) 2025-06-19 — — WO claimed
WO-2025059190-A2 POLYPEPTIDE CONJUGATION COMPOSITIONS AND METHODS OF USE CATENA BIOSCIENCES, INC. (US) 2025-03-20 — — WO claimed
US-11419944-B2 Non-linear self-immolative linkers and conjugates thereof BYONDIS B.V. (NL) 2022-08-23 — — US claimed
US-11052155-B2 Conjugates of CC-1065 analogs and bifunctional linkers SYNTARGA BV (NL) 2021-07-06 — — US claimed
CN-106749665-B Conjugates of CC-1065 analogs and bifunctional linkers 辛塔佳有限公司 2021-03-26 — — CN claimed
US-20200297859-A1 NON-LINEAR SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF BYONDIS B.V. (NL) 2020-09-24 — — US claimed
EP-3525826-B1 NON-LINEAR SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF BYONDIS BV (NL) 2020-07-22 — — EP claimed
EP-3525826-A1 NON-LINEAR SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF Synthon Biopharmaceuticals B.V. (NL) 2019-08-21 — — EP claimed
EP-2173739-A1 SUBSTITUTED CC-1065 ANALOGS AND THEIR CONJUGATES Syntarga B.V. (NL) 2010-04-14 — — EP claimed
US-20090318668-A1 Water-Soluble CC-1065 Analogs and Their Conjugates Georg-August-Universität Göttingen Stiftung öffentlichen Rechts (ohne Bereich Humanmedizin) (DE) 2009-12-24 — — US claimed
CN-100522249-C Elongated multiple spacers in activatable prodrugs SINTAGAR B V (NL) 2009-08-05 — — CN claimed
WO-2009017394-A1 SUBSTITUTED CC-1065 ANALOGS AND THEIR CONJUGATES SYNTARGA B.V. (NL) 2009-02-05 — — WO claimed
EP-1994000-A2 WATER-SOLUBLE CC-1065 ANALOGS AND THEIR CONJUGATES Syntarga B.V. (NL) 2008-11-26 — — EP claimed
US-7420029-B2 Tissue-specific transporter inhibitor JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2008-09-02 — — US claimed
WO-2007089149-A2 WATER-SOLUBLE CC-1065 ANALOGS AND THEIR CONJUGATES SYNTARGA B.V. (NL) 2007-08-09 — — WO claimed
US-20040191211-A1 Tissue-specific transporter inhibitor JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2004-09-30 — — US claimed
CN-1511044-A Elogated and multiple spacers in activatible prodrugs — 2004-07-07 — — CN claimed
EP-1405644-A1 TISSUE-SPECIFIC TRANSPORTER INHIBITOR Japan Science and Technology Agency (JP) 2004-04-07 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318668-A1 Water-Soluble CC-1065 Analogs and Their Conjugates PCNA, DCK, BAD FOLH1 1106/4885CPB2 2100/4885SLC6A5 177/4885
US-20040191211-A1 Tissue-specific transporter inhibitor SLC10A2, SLC10A1, SLC16A1 FOLH1 159/4885CPB2 955/4885SLC6A5 79/4885
US-20200297859-A1 NON-LINEAR SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF DLST, ADSL, LANCL1 FOLH1 736/4885CPB2 3797/4885SLC6A5 2697/4885
US-11052155-B2 Conjugates of CC-1065 analogs and bifunctional linkers PCNA, DCLRE1A, CDC5L FOLH1 603/4885CPB2 1600/4885SLC6A5 678/4885
US-11419944-B2 Non-linear self-immolative linkers and conjugates thereof DLST, ADSL, LANCL1 FOLH1 736/4885CPB2 3797/4885SLC6A5 2697/4885
US-20260027241-A1 Near-Infrared Dyes And Conjugates For Targeting Tumors ADAMTS1, ADAMTS4, ADAMTS5 FOLH1 50/4885CPB2 296/4885SLC6A5 3391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback